Studies led by Mount Sinai researchers reinforces potential benefits of new stroke-prevention drug

(New Orleans, Louisiana March 8) Researchers at Mount Sinai School of Medicine announced an analysis of pooled data from two Phase III stroke prevention trials today at the American College of Cardiology (ACC) annual meeting in New Orleans, Louisiana. Pooled data demonstrated that ximelagatran, a new type of anti-clotting medication currently under FDA review, is as effective as current treatment warfarin for the prevention of stroke and systemic embolic events in men and women with nonvalvular atrial fibrillation (AF).

Although more men are affected with AF than women, the risk of AF-related strokes is greater among women. Warfarin is effective in preventing stroke but can be associated with bleeding, which occurs more often in women than men. Pooled data presented today on the SPORTIF (Stroke Prevention by ORal Thrombin Inhibitor in atrial Fibrillation) III and V studies are the first to compare ximelagatran in the men and women subgroup population.

This analysis on SPORTIF III and V compared the efficacy and safety of 5,075 men and 2,257 women treated with either ximelagatran or dose-adjusted warfarin, and showed that EXANTA is at least as effective as warfarin in preventing strokes and systemic embolic events. During 11,233 patient-years (mean 19 months) exposure, 72 primary events (2.2 percent per year treated with ximelagatran vs. 2.0 percent per year treated with warfarin) occurred in women and 112 primary events (1.4 percent per year treated with ximelagatran vs. 1.5 percent per year treated with warfarin) occurred in men. Ximelagatran was also associated with lower bleeding rates than warfarin, and the incidence of major and minor bleeding was greater among women than men (35.4 percent per year in women and 30.1 percent per year in men on ximelagatran vs. 44.8 percent per year in women vs. 36.3 percent per year in men on warfarin).

"Pooled analysis of this study reinforces the potential benefits of ximelagatran as a treatmen

Contact: Mount Sinai Press Office
The Mount Sinai Hospital / Mount Sinai School of Medicine

Page: 1 2 3

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies demonstrate positive data in treatment of hepatitis C
8. Studies examine risk factors and potential consequences associated with prehypertension
9. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
10. Studies identify risk factors for colon cancer
11. Studies indicate healthy eating may affect cancer development, improve digestive system

Post Your Comments:

(Date:7/1/2020)... ... July 01, 2020 , ... Dexur’s analysis ... OrthoColorado Hospital , Porter Adventist Hospital , and Sky Ridge Medical ... Hip & Knee Replacement. Dexur’s value analysis tracks a patient’s episode of care from ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Pool & ... and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance ... seeking member participation on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment ...
(Date:6/28/2020)... ... June 27, 2020 , ... The secret of surviving a pandemic with one’s ... toilet paper. Yet, it was the first product to disappear off the shelves when ... you have stockpiled, the less need to venture out, the longer you can “survive”. ...
(Date:6/24/2020)... ... ... Evolved Naturals, a new brand of CBD health and beauty products, announced ... launched website showcases a variety of health and beauty CBD products including ... skincare & topical products . , Doug Gee, the CEO of Evolved Naturals, ...
(Date:6/24/2020)... ... ... Skyroam , the developer of patented virtual SIM (vSIM) technology for ... of enterprise software for testing laboratories, in which its Skyroam Solis Lite 4G LTE ... Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global effort that ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... Va. (PRWEB) , ... July 01, 2020 , ... ... edition of The International Business Awards® is Tuesday, July 28. ... business awards competition. In 2019 the competition attracted more than 4,000 nominations ...
(Date:6/28/2020)... ... ... CPAP Store USA, known for its one of a kind concept retail ... expanding at a rapid rate. Today, CPAP store USA is excited to announce the ... at 3920 Rosemeade Parkway, Suite 150, Dallas, Texas 75287. , Opening the new retail ...
(Date:6/25/2020)... ... 25, 2020 , ... The Heritage Downtown Active Senior Living Apartment Homes in ... over 100,000 positive cases of the coronavirus in the United States to date, their ... Heritage Downtown, their family members, as well as the Walnut Creek community. , ...
Breaking Medicine Technology:
Cached News: